| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | M170940PMI |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| BINDING AGENT | Mesothelin binding agent | PubMed |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Mesothelioma | 2 | D008654 | ClinicalTrials |
| Neoplasms | 2 | D009369 | ClinicalTrials |
| Mesothelioma | 2 | D008654 | ClinicalTrials |
| Pancreatic Neoplasms | 2 | D010190 | ClinicalTrials |
| Neoplasms | 2 | D009369 | ClinicalTrials |
| Lung Neoplasms | 2 | D008175 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 1 | D002289 | ClinicalTrials |
| Ovarian Neoplasms | 1 | D010051 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1375258-01-7 |
| ChEMBL | CHEMBL2109629 |
| FDA SRS | M170940PMI |
CONTENTS